Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : RMGG -- Ignore unavailable to you. Want to Upgrade?

To: Coop who wrote (83)	6/2/1998 8:12:00 AM
From: Gator	Read Replies (1) \| Respond to of 1170

Hey Coop, stop being so abstemious! Had to look that one up. If the Litchfield/Global/Biofarm entity is going to have a controlling interest (i.e. majority shareholder) of RMGG and RMGG is going to continue as a separate stock, it would stand to reason that Litchfield & Co. would like to see RMGG stock price go up. So it sounds like Litchfield is financing the Fuzhou Fujiang acquisition for RMGG in return for controlling interest (shares) in RMGG. Global and Biofarm are merging (keeping Biofarm name), and Litchfield will be transferring its assets (which include controlling interest in RMGG) into Biofarm. Biofarm, with its now controlling interest in RMGG will funnel Biofarm products into China through Fuzhou Fujiang. My question is what kind of royalty or revenue (if any) will RMGG get to keep on their books from selling Biofarm products through FF? The picture just keeps getting better. Gator